Coldstream Capital Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

Coldstream Capital Management’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-15,670	Closed	-$70K	–	237
2016 Q1	$70K	Buy	+15,670	New	+$74.7K	0.01%	256
2015 Q1	–	Sell	-21,310	Closed	-$127K	–	146
2014 Q4	$127K	Sell	21,310 -5,825	-21%	-$29.9K	0.04%	187
2014 Q3	$134K	Hold	27,135	–	–	0.04%	172
2014 Q2	$122K	Hold	27,135	–	–	0.04%	187
2014 Q1	$122K	Buy	+27,135	New	+$129K	0.04%	176
2013 Q3	–	Sell	-34,920	Closed	-$178K	–	183
2013 Q2	$178K	Buy	+34,920	New	+$174K	0.06%	161

Other funds holding CPIX

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Coldstream Capital Management's CPIX Position: Q2 2016 in Review

Coldstream Capital Management sold out of Cumberland Pharmaceuticals (CPIX) in Q2 2016, closing a stake of 15,670 shares — an estimated $70K sold.

Coldstream Capital Management first reported a position in CPIX in Q2 2013 and held it in 6 quarters. The position peaked at $178K in Q2 2013. 44 funds tracked by Wall St. Rank hold CPIX as of Q2 2016.

Coldstream Capital Management reported no remaining Cumberland Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
Coldstream Capital Management sold 15,670 Cumberland Pharmaceuticals shares in Q2 2016, an estimated $70K.
Coldstream Capital Management first reported a position in Cumberland Pharmaceuticals in Q2 2013 and held it in 6 quarters.
Coldstream Capital Management's Cumberland Pharmaceuticals position peaked at $178K in Q2 2013.
44 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2016.

Based on Coldstream Capital Management's 13F filing for Q2 2016, filed 9 Aug 2016.